DIVA Laboratories, Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 207.25 million compared to TWD 236.2 million a year ago. Net income was TWD 19.42 million compared to TWD 22.63 million a year ago. Basic earnings per share from continuing operations was TWD 0.33 compared to TWD 0.39 a year ago. Diluted earnings per share from continuing operations was TWD 0.33 compared to TWD 0.38 a year ago.
For the nine months, sales was TWD 688.98 million compared to TWD 653.88 million a year ago. Net income was TWD 52.58 million compared to TWD 27.97 million a year ago. Basic earnings per share from continuing operations was TWD 0.9 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 0.89 compared to TWD 0.48 a year ago.